搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bacillus halodurans DNA gyrase subunit A (gyrA), partial CSB-YP526215BQS
CSB-EP526215BQS
CSB-BP526215BQS
CSB-MP526215BQS
CSB-EP526215BQS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halomonas halodenitrificans Nitric oxide reductase subunit C (norC), partial CSB-YP526216HTY1
CSB-EP526216HTY1
CSB-BP526216HTY1
CSB-MP526216HTY1
CSB-EP526216HTY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Adenine deaminase (ade), partial CSB-YP526217BUD
CSB-EP526217BUD
CSB-BP526217BUD
CSB-MP526217BUD
CSB-EP526217BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP526219BUD
CSB-EP526219BUD
CSB-BP526219BUD
CSB-MP526219BUD
CSB-EP526219BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized protein BB_0027 (BB_0027), partial CSB-YP526220BUD
CSB-EP526220BUD
CSB-BP526220BUD
CSB-MP526220BUD
CSB-EP526220BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Phosphate transport system protein phoU homolog (phoU) CSB-YP526221BUD
CSB-EP526221BUD
CSB-BP526221BUD
CSB-MP526221BUD
CSB-EP526221BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized protein BB_0048 (BB_0048) CSB-YP526222BUD
CSB-EP526222BUD
CSB-BP526222BUD
CSB-MP526222BUD
CSB-EP526222BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized protein BB_0063 (BB_0063), partial CSB-YP526223BUD1
CSB-EP526223BUD1
CSB-BP526223BUD1
CSB-MP526223BUD1
CSB-EP526223BUD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Probable cysteine desulfurase (csd) CSB-YP526224BUD
CSB-EP526224BUD
CSB-BP526224BUD
CSB-MP526224BUD
CSB-EP526224BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized protein BB_0095 (BB_0095) CSB-YP526225BUD
CSB-EP526225BUD
CSB-BP526225BUD
CSB-MP526225BUD
CSB-EP526225BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP526226BUD
CSB-EP526226BUD
CSB-BP526226BUD
CSB-MP526226BUD
CSB-EP526226BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi UPF0073 membrane protein BB_0117 (BB_0117), partial CSB-YP526227BUD1
CSB-EP526227BUD1
CSB-BP526227BUD1
CSB-MP526227BUD1
CSB-EP526227BUD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi 30S ribosomal protein S2 (rpsB) CSB-YP526228BUD
CSB-EP526228BUD
CSB-BP526228BUD
CSB-MP526228BUD
CSB-EP526228BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized protein BB_0173 (BB_0173), partial CSB-YP526229BUD1
CSB-EP526229BUD1
CSB-BP526229BUD1
CSB-MP526229BUD1
CSB-EP526229BUD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi 50S ribosomal protein L35 (rpmI) CSB-YP526230BUD
CSB-EP526230BUD
CSB-BP526230BUD
CSB-MP526230BUD
CSB-EP526230BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi UDP-N-acetylmuramyl-tripeptide synthetase (murE), partial CSB-YP526231BUD
CSB-EP526231BUD
CSB-BP526231BUD
CSB-MP526231BUD
CSB-EP526231BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Serine--tRNA ligase (serS) CSB-YP526232BUD
CSB-EP526232BUD
CSB-BP526232BUD
CSB-MP526232BUD
CSB-EP526232BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Oligoendopeptidase F homolog (pepF), partial CSB-YP526233BUD
CSB-EP526233BUD
CSB-BP526233BUD
CSB-MP526233BUD
CSB-EP526233BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP526234BUD
CSB-EP526234BUD
CSB-BP526234BUD
CSB-MP526234BUD
CSB-EP526234BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Glutamyl-tRNA (Gln) amidotransferase subunit C CSB-YP526235BUD
CSB-EP526235BUD
CSB-BP526235BUD
CSB-MP526235BUD
CSB-EP526235BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>